Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 90 record(s)

Req # A-2021-10638

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and BC Ministry of Health, Pharmaceutical Services Division over planned reforms to the PMPRB…

Organization: Patented Medicine Prices Review Board Canada

6 page(s)
November 2021

Req # A-2021-10631

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Amgen Canada Inc over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8,…

Organization: Patented Medicine Prices Review Board Canada

5 page(s)
November 2021

Req # A-2021-10625

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and AbbVie over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 7, 2021. Do not…

Organization: Patented Medicine Prices Review Board Canada

1 page(s)
October 2021

Req # A-2021-10630

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and the Canadian Cancer Society over planned reforms to the PMPRB Guidelines from June 1, 2019 to…

Organization: Patented Medicine Prices Review Board Canada

1 page(s)
October 2021

Req # A-2021-10777

Copies of all communications between the PMPRB and the clerk of the Health Committee Jean-François Pagé from May 22, 2021 to June 11, 2021. Include internal emails between the PMPRB executives, particularly Tanya Potashnik, Douglas Clark, Mitchell…

Organization: Patented Medicine Prices Review Board Canada

3 page(s)
October 2021

Req # A-2021-19384

The daily calendar of meetings, calls and other taskings for Tanya Potashnik from May 1, 2021 to October 14, 2021.

Organization: Patented Medicine Prices Review Board Canada

24 page(s)
October 2021

Req # A-2021-12332

Copies of all final IQVIA contracts and accompanying briefing materials, if applicable, for the contracts associated with the following procurement ID numbers: 160005 A3; 160005 A2; 160005 A5; 160005 A6; 160005 A7; 180030; 16NL008 A3; 16NL021 A4;…

Organization: Patented Medicine Prices Review Board Canada

70 page(s)
August 2021

Req # A-2021-11082

Copies of all documents presented, and shared with participants related to the symposium organized by the PMPRB with academics during the week of May 31, 2021.

Organization: Patented Medicine Prices Review Board Canada

207 page(s)
July 2021

Req # A-2021-07238

Copies of all information, data, document, or correspondence concerning the PMPRB's classification of the following drug products: NOVORAPID and FIASP, each a product of NOVO NORDISK CANADA INC, a corporation located at 101-2476 Argentia Road,…

Organization: Patented Medicine Prices Review Board Canada

12 page(s)
May 2021

Req # A-2021-07891

Copies of all emails and meeting summaries regarding the PMPRB's consultation with IMC about the new PMPRB guidelines.

Organization: Patented Medicine Prices Review Board Canada

75 page(s)
May 2021
Date modified: